Novel mechanisms and clinical trial endpoints in intestinal fibrosis.

Wang, Jie; Lin, Sinan; Brown, Jonathan Mark; van Wagoner, David; Fiocchi, Claudio; Rieder, Florian

Wang, Jie; Lin, Sinan; Brown, Jonathan Mark; van Wagoner, David; Fiocchi, Claudio; Rieder, Florian.

Afiliação

Wang J; Henan Key Laboratory of Immunology and Targeted Drug, Xinxiang Medical University, Xinxiang, China.
Lin S; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Brown JM; Department of Inflammation and Immunity, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
van Wagoner D; Department of Gastroenterology and Hepatology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Fiocchi C; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Rieder F; Department of Cardiovascular and Metabolic Sciences, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.

Immunol Rev ; 302(1): 211-227, 2021 07.

Article em En | MEDLINE | ID: mdl-33993489

Assuntos

Doença de Crohn; Doenças Inflamatórias Intestinais; Constrição Patológica/patologia; Fibrose; Humanos; Intestinos/patologia

Palavras-chave

creeping fat; cytokine; inflammatory bowel disease; intestinal fibrosis; myofibroblasts; single-cell RNA sequencing

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Inflamatórias Intestinais / Doença de Crohn Limite: Humans Idioma: En Revista: Immunol Rev Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google